Minimally Invasive Freezing Balloon Technology for AF ablation.Amplify’d from www.austindailyherald.com
Mayo Clinic is the first in the U.S. to use the first minimally invasive freezing balloon technology for the treatment of atrial fibrillation (AF) approved in December by the U.S. Food and Drug Administration. The first patient received the treatment Tuesday, Jan. 4.
The technology is used to treat drug refractory recurrent symptomatic paroxysmal AF, a type of AF in which irregular heartbeats in the upper chambers of the heart start and stop suddenly on their own. The new system uses a balloon-based technology delivered through a catheter with a coolant rather than heat to create circumferential lesions around the pulmonary vein to block the conduction of AF in cardiac tissues.
“This approach provides a single ablative means of eliminating problematic AF in patients who failed drug therapy,” said Douglas Packer, M.D., Mayo Clinic cardiologist.
single ablative means of eliminating problematic AF in patients who failed drug therapy
See this Amp at http://bit.ly/f1ghKM